Skip to main content
main-content

Updates in sarcoma from ASCO and ESMO 2018

Introduction

Presented by Jean-Yves Blay (Professor of Medical Oncology, Leon Berard Center, Lyon, France)

Here we provide a downloadable slide collection, based on a webinar presented by World Sarcoma Network Chairman Professor Jean-Yves Blay, which highlights and summarizes key recent findings in sarcoma presented at the 2018 ASCO Annual Meeting and the 2018 ESMO Congress. The congress presentations were specially selected for inclusion by Professor Blay.

Downloadable slide collection

Click on the images below to download the slide collection in English and French.

Updates in sarcoma from ASCO and ESMO 2018

New Content Item

About the presenter

New Content Item Professor Jean-Yves Blay is Professor of Medicine at the Université Claude Bernard from Lyon, France, and the President of the EORTC (European Organisation for Research and Treatment of Cancer). He is Chairman of the World Sarcoma Network and Chair of the French Sarcoma Group. He has been the scientific director of the Canceropole CLARA and the National Representative for the European Society of Medical Oncology. He is currently member of the international editorial board of Lancet Oncology, European Journal of Cancer, and Bull Cancer. Professor Blay has published over 300 peer-reviewed articles, in addition to over 200 abstracts and book chapters. His research interests focus on the biology of sarcomas and breast carcinomas and relation between tumor microenvironment and malignant cells with the goal of clinical applications in the fields of diagnosis, prognosis and treatment. He is also involved in clinical and biological research in the field of soft tissue sarcomas. He is an active member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the American Association of Cancer Research (AACR) and has served as member of Scientific Committees for the ESMO and AACR meetings.

Funding acknowledgment

This educational initiative was funded by Eli Lilly and Company.

---

> CLICK HERE FOR FURTHER RESOURCES IN SARCOMA